New discoveries of AIDS treatment

Researchers at a hospital in Spain recently announced that they will conduct a therapeutic vaccine trial in 2014 for HIV-infected patients.

This therapeutic vaccine is used to treat the disease rather than prevent it. The hospital in Barcelona said that the trial will be carried out in the hospital to tie in with the four-year research plan conducted by the hospital together with other hospitals in Spain, Belgium and the Netherlands. Jardell, director of the infectious disease department at the hospital, said: "The trial is to achieve the goal of functional healing. This means that we can control HIV in patients without having to provide antiretroviral therapy for them for the rest of their lives." More than 3 million people are infected with HIV, most of whom are people in developing countries. However, the commonly used anti-reverse transcription combination therapy has proven to be effective in preventing clinical deterioration and death, but it cannot eradicate infection itself, so there is an urgent need for other therapies. .

In the same month, however, researchers at a affiliated hospital at Harvard University in the United States announced that two AIDS patients who appeared to be cured after receiving a bone marrow transplant had relapsed and that the HIV virus had reappeared in their bodies. This news can be described as a severe blow to the medical community and the long-awaited patients who are struggling to find breakthroughs in AIDS treatment.